Skip to main content

STIFEL FINANCIAL CORP

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 720672 ST. LOUIS, MO

Position in RXRX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$2,385,167
-$28,537 QoQ
Shares Held
776,928
+31.6% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. RXRX ranks #26 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RXRX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,385,167 776,928
2025-12-31 $2,413,704 590,148
2025-09-30 $2,160,839 442,795
2025-06-30 $1,295,825 256,092
2025-03-31 $990,599 187,259
2024-12-31 $1,080,834 159,887
2024-09-30 $1,067,434 161,978
2024-06-30 $816,561 108,875
2024-03-31 $442,756 44,409
2023-12-31 $268,083 27,189